Antibody Effector Functions Mediated by Fcγ-Receptors Are Compromised during Persistent Viral Infection

被引:57
作者
Wieland, Andreas [1 ,2 ]
Shashidharamurthy, Rangaiah [3 ]
Kamphorst, Alice O. [1 ,2 ]
Han, Jin-Hwan [1 ,2 ]
Aubert, Rachael D. [1 ,2 ]
Choudhury, Biswa P. [5 ]
Stowell, Sean R. [3 ]
Lee, Junghwa [1 ,2 ]
Punkosdy, George A. [1 ,2 ]
Shlomchik, Mark J. [4 ]
Selvaraj, Periasamy [3 ]
Ahmed, Rafi [1 ,2 ]
机构
[1] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[4] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA
[5] Univ Calif San Diego, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
LYMPHOCYTIC CHORIOMENINGITIS VIRUS; IMMUNE-COMPLEX DISEASE; T-CELL RESPONSES; IN-VIVO; B-CELLS; ANTITUMOR ACTIVITIES; DENDRITIC CELLS; BREAST-CANCER; STEM-CELLS; THERAPY;
D O I
10.1016/j.immuni.2015.01.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell dysfunction is well documented during chronic viral infections but little is known about functional abnormalities in humoral immunity. Here we report that mice persistently infected with lymphocytic choriomeningitis virus (LCMV) exhibit a severe defect in Fc gamma-receptor (Fc gamma R)-mediated antibody effector functions. Using transgenic mice expressing human CD20, we found that chronic LCMV infection impaired the depletion of B cells with rituximab, an anti-CD20 antibody widely used for the treatment of B cell lymphomas. In addition, Fc gamma R-dependent activation of dendritic cells by agonistic anti-CD40 antibody was compromised in chronically infected mice. These defects were due to viral antigen-anti-body complexes and not the chronic infection per se, because Fc gamma R-mediated effector functions were normal in persistently infected mice that lacked LCMV-specific antibodies. Our findings have implications for the therapeutic use of antibodies and suggest that high levels of pre-existing immune complexes could limit the effectiveness of antibody therapy in humans.
引用
收藏
页码:367 / 378
页数:12
相关论文
共 54 条
[1]   A requirement for FcγR in antibody-mediated bacterial toxin neutralization [J].
Abboud, Nareen ;
Chow, Siu-Kei ;
Saylor, Carolyn ;
Janda, Alena ;
Ravetch, Jeffery V. ;
Scharff, Matthew D. ;
Casadevall, Arturo .
JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (11) :2395-2405
[2]   Depletion of B cells in murine lupus: Efficacy and resistance [J].
Ahuja, Anupama ;
Shupe, Jonathan ;
Dunn, Robert ;
Kashgarian, Michael ;
Kehry, Marilyn R. ;
Shlomchik, Mark J. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (05) :3351-3361
[3]   An Acquired Defect in IgG-Dependent Phagocytosis Explains the Impairment in Antibody-Mediated Cellular Depletion in Lupus [J].
Ahuja, Anupama ;
Teichmann, Lino L. ;
Wang, Haowei ;
Dunn, Robert ;
Kehry, Marilyn R. ;
Shlomchik, Mark J. .
JOURNAL OF IMMUNOLOGY, 2011, 187 (07) :3888-3894
[4]   The future of anti-CD20 monoclonal antibodies: are we making progress? [J].
Alduaij, Waleed ;
Illidge, Tim M. .
BLOOD, 2011, 117 (11) :2993-3001
[5]   Down-regulation of CD20 on B cells upon CD40 activation [J].
Anolik, J ;
Looney, RJ ;
Bottaro, A ;
Sanz, I ;
Young, F .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (09) :2398-2409
[6]   Restoring function in exhausted CD8 T cells during chronic viral infection [J].
Barber, DL ;
Wherry, EJ ;
Masopust, D ;
Zhu, BG ;
Allison, JP ;
Sharpe, AH ;
Freeman, GJ ;
Ahmed, R .
NATURE, 2006, 439 (7077) :682-687
[7]   Cutting edge: Rapid in vivo killing by memory CD8 T cells [J].
Barber, DL ;
Wherry, EJ ;
Ahmed, R .
JOURNAL OF IMMUNOLOGY, 2003, 171 (01) :27-31
[8]   B lymphocyte memory:: Role of stromal cell complement and FcγRIIB receptors [J].
Barrington, RA ;
Pozdnyakova, O ;
Zafari, MR ;
Benjamin, CD ;
Carroll, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (09) :1189-1199
[9]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[10]   Broadly Neutralizing Anti-HIV-1 Antibodies Require Fc Effector Functions for In Vivo Activity [J].
Bournazos, Stylianos ;
Klein, Florian ;
Pietzsch, John ;
Seaman, Michael S. ;
Nussenzweig, Michel C. ;
Ravetch, Jeffrey V. .
CELL, 2014, 158 (06) :1243-1253